Peter Buehlmayer

A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis

Jean Quancard, Birgit Bollbuck, Philipp Janser et al. · Chemistry & Biology · 2012 · 128 citations

Life Sciences, Neurology, Neuroscience +10

An Oral Sphingosine 1-Phosphate Receptor 1 (S1P₁) Antagonist Prodrug with Efficacy in Vivo: Discovery, Synthesis, and Evaluation

Daniela Angst, Philipp Janser, Jean Quancard et al. · Journal of Medicinal Chemistry · 2012 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck

Nina Gommermann, Peter Buehlmayer, Anette von Matt et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Synthesis of Chiral Analoguesof FTY720 and its Phosphate

Klaus Hinterding, Sylvain Cottens, Rainer Albert et al. · Synthesis · 2003 · 24 citations

Pharmacy, Immunology, Medicinal Chemistry +4

Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists

Heinrich Rueeger, Marc Gerspacher, Peter Buehlmayer et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11